Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Administration of supplemental sliding scale insulin for correction of hyperglycemia in non–intensive care unit (ICU) patients with type 2 diabetes is frequently used with basal-bolus insulin regimens. In this noninferiority randomized controlled trial we tested whether glycemic control is similar with and without aggressive sliding scale insulin treatment before meals and bedtime in patients treated with basal-bolus insulin regimens. RESEARCH DESIGN AND METHODS: Patients with type 2 diabetes with admission blood glucose (BG) 140–400 mg/dL treated with basal-bolus insulin were randomized to intensive (correction for BG >140 mg/dL, n = 108) or to nonintensive (correction for BG >260 mg/dL, n = 107) administration of rapid-acting sliding scale insulin before meals and bedtime. The groups received the same amount of sliding scale insulin for BG >260 mg/dL. Primary outcome was difference in mean daily BG levels between the groups during hospitalization. RESULTS: Mean daily BG in the nonintensive group was noninferior to BG in the intensive group with equivalence margin of 18 mg/dL (intensive 172 ± 38 mg/dL vs. nonintensive 173 ± 43 mg/dL, P = 0.001 for noninferiority). There were no differences in the proportion of target BG readings of 70–180 mg/dL, <70 or <54 mg/dL (hypoglycemia), or >350 mg/dL (severe hyperglycemia) or total, basal, or prandial insulin doses. Significantly fewer subjects received sliding scale insulin in the nonintensive (n = 36 [34%]) compared with the intensive (n = 98 [91%] [P < 0.0001]) group with no differences in sliding scale insulin doses between the groups among those who received sliding scale insulin (intensive 7 ± 4 units/day vs. nonintensive 8 ± 4 units/day, P = 0.34). CONCLUSIONS: Among non-ICU patients with type 2 diabetes on optimal basal-bolus insulin regimen with moderate hyperglycemia (BG <260 mg/dL), a less intensive sliding scale insulin treatment did not significantly affect glycemic control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RCTs have shown that treatment with a basal prandial regimen using insulin analogs improved glycemic control with fewer hospital complications in general medical and surgical persons with T2D compared with sliding-scale regular insulin alone.92,107,108,1333–1336”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1334]
Citations
Cites
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationMoghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Self-citationFurnary, A. P., Zerr, K. J., Grunkemeier, G. L., & Starr, A. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00014-4 · Cited by 1,230
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
Self-citationUmpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011) · Diabetes Care · doi:10.2337/dc10-1407 · Cited by 720
Self-citationUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationMcAlister, F. A., Majumdar, S. R., Blitz, S., Rowe, B. H., Romney, J., & Marrie, T. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.810 · Cited by 441
Diabetes and Coronary Artery Bypass Surgery
McAlister, F. A., Man, J., Bistritz, L., Amad, H., & Tandon, P. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1518 · Cited by 271
Umpierrez, G. E., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Newton, C., Jacobs, S., Rizzo, M., Peng, L., Reyes, D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1988 · Cited by 222
Self-citationGalindo, R. J., Migdal, A. L., Davis, G. M., Urrutia, M. A., Albury, B., Zambrano, C., Vellanki, P., Pasquel, F. J., Fayfman, M., Peng, L., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2073 · Cited by 181
Self-citationDavis, G. M., Spanakis, E. K., Migdal, A. L., Singh, L. G., Albury, B., Urrutia, M. A., Zamudio-Coronado, K. W., Scott, W. H., Doerfler, R., Lizama, S., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2856 · Cited by 160
Self-citationPrognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage: The INTERACT2 Study
Saxena, A., Anderson, C. S., Wang, X., Sato, S., Arima, H., Chan, E., Venturelli, P. M., Delcourt, C., Robinson, T. G., Stapf, C., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.011627 · Cited by 159
Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action
Draznin, B., Gilden, J., Golden, S. H., Inzucchi, S. E., & for the PRIDE investigators (2013) · Diabetes Care · doi:10.2337/dc12-2508 · Cited by 145
Jones, C. E., Graham, L. A., Morris, M. S., Richman, J. S., Hollis, R. H., Wahl, T. S., Copeland, L. A., Burns, E. A., Itani, K. M. F., & Hawn, M. T. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.2350 · Cited by 90
Ainla, T., Baburin, A., Teesalu, R., & Rahu, M. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01625.x · Cited by 75
Pasquel, F. J., Gomez-Huelgas, R., Anzola, I., Oyedokun, F., Haw, J. S., Vellanki, P., Peng, L., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-1835 · Cited by 55
Self-citationVellanki, P., Bean, R., Oyedokun, F. A., Pasquel, F. J., Smiley, D., Farrokhi, F., Newton, C., Peng, L., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc14-1796 · Cited by 36
Self-citationCoan, K. E., Schlinkert, A. B., Beck, B. R., Haakinson, D. J., Castro, J. C., Apsey, H. A., Schlinkert, R. T., & Cook, C. B. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700410 · Cited by 31
Overcoming Clinical Inertia in the Management of Postoperative Patients with Diabetes
Apsey, H. A., Coan, K. E., Castro, J. C., Jameson, K. A., Schlinkert, R. T., & Cook, C. B. (2013) · Endocrine Practice · doi:10.4158/ep13366.or · Cited by 28
Treatment Intensification and Blood Glucose Control Among Hospitalized Diabetic Patients
Matheny, M. E., Shubina, M., Kimmel, Z. M., Pendergrass, M., & Turchin, A. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0468-x · Cited by 27
Ekanayake, P. S., Juang, P. S., & Kulasa, K. M. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01364-2 · Cited by 21
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationKang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 83
Kanjee, Z., Brown, F. M., Taxin, Z. H., & Smetana, G. W. (2024) · Annals of Internal Medicine · doi:10.7326/annals-24-01100 · Cited by 5
Ammar, A., Sorochak, N., Paxton, R. A., Lipari, M., & Giuliano, C. A. (2025) · Journal of Intensive Care Medicine · doi:10.1177/08850666251371709 · Cited by 2
Pacheco, S. T., Weber, F. L. R., Greene, E. J. D., & Valdivia, G. G. (2025) · Acta Médica Grupo Ángeles · doi:10.35366/119342 · Cited by 2
Metadata
- Authors
- Vellanki, P., Cardona, S., Galindo, R. J., Urrutia, M. A., Pasquel, F. J., Davis, G. M., Fayfman, M., Migdal, A., Peng, L., & Umpierrez, G. E.
- Affiliations
- Emory University (US)
- Corresponding author
- Vellanki, Priyathama
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2022-06-08
- Volume
- 45
- Issue
- 10
- Pages
- 2217-2223
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC9643128
- OpenAlex
- W4282938962
- Cited by
- 10
- References
- 22
- Citations by year
- 2025: 4 · 2024: 3 · 2023: 1 · 2022: 2
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR002378)
- National Institute of General Medical Sciences (K23GM128221)
- National Institute of Diabetes and Digestive and Kidney Diseases (K23DK113241, K23DK122199, K23DK123384, P30DK111024)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, multiple daily insulin injections, sliding scale insulin, intensive insulin therapy, hyperglycemia, glycemic control, hospitalized patients, non-intensive care units, hypoglycemia, non-inferiority, insulin dose reduction, glycemic targets, rapid-acting insulin, non-ICU patients
- MeSH terms
- Insulin Glargine, Blood Glucose, Diabetes Mellitus, Type 2, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin, Regular, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.